Brief: China Biotech Services Says Unit Applied To CDE For Registration Of Clinical Trial Of LY007
05/11/2020 15:34
Nov 5 (Reuters) - China Biotech Services Holdings Ltd
8037.HK :
* UNIT APPLIED TO CDE OF NMPA FOR REGISTRATION OF CLINICAL
TRIAL
OF LY007 CELLULAR INJECTION
* UNIT'S APPLICATION HAS BEEN ACCEPTED
Source text for Eikon: urn:newsml:reuters.com:*:nHKSbM0p51
Further company coverage: 8037.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on China Biotech Services Holdings
See all newsBrief: China Biotech Services Enters Cooperation Agreement
Brief: China Biotech Services Says HY Revenue From Cont Ops Hk$37.23 Million
Brief: China Biotech Services Expects HY Net Profit Of Not Less Than HK$15.0 MLN
Brief: China Biotech Services Enters Master Collaboration Agreement With Stella Pharma
Brief: China Biotech Services Says BGI Songhe Advances RMB30 Million Loan To Pengbo (Hainan)